Miguel Aguirre, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 Fax: 254-202-5849 |
Whitney B Jasso, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-5800 |
Sarah Newell, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |
Mrs. Rebecca Jane Osborne, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-214-7563 |
Ms. Sylvia Monica Skucha, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 Fax: 254-202-5849 |
Jeffrey T Mims, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 Fax: 254-202-5849 |
Chad Patete, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |
Mr. Alan Sims, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 Fax: 254-202-5849 |
Benjamin Morgan, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |
News Archive
Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for cabazitaxel solution; IV (infusion) in 60 mg/1.5 mL (40 mg/mL) strength, a generic version of Jevtana® by Sanofi.
Researchers have localized two new genes that are associated with fever-related seizures that occur in infancy and childhood, according to a study published in the April 24, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
In an Australian first, Cancer Australia today launched a Framework to improve the outcomes and experiences of people affected by lung cancer – the leading cause of cancer death in Australia.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that the U.S. Food and Drug Administration has granted 510(K) clearance to market Vitala, an exceptionally innovative, non-intrusive ostomy continence control device, for people with an end colostomy.
› Verified 8 days ago